Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Rev Gastroenterol Peru ; 39(1): 12-20, 2019.
Artículo en Español | MEDLINE | ID: mdl-31042232

RESUMEN

OBJECTIVES: Establish the prevalence of gastric polyps detected by upper gastrointestinal endoscopy in patients older than 18 years old during the period from 2007 - 2016 in Cayetano Heredia Hospital. MATERIALS AND METHODS: Retrospective cross-sectional study, performed with data from the gastric biopsies reports of patients that have undergone upper gastrointestinal endoscopy between January 2007 and July 2016. Demographic data, endoscopic characteristics of the polyps and associated histological changes of the surrounding gastric mucosa were evaluated, which were subjected to statistical analysis using STATA v14.2. RESULTS: In a population of 16 552 endoscopies, 407 gastric polyps biopsies were found. These results give a prevalence of 2.5% .Gastric polyps were detected predominantly in women (62.38%). The median age was 61 years (52-71 years). The most frequent histological type was the fundic gland polyp (FGP) (44.85%), followed by the hyperplastic (38.48%) and adenomatous (15.23%) polyp. The most frequent location was in the fundus / corpus (48.65%, p = 0.001). The presence of Hp was detected in 30.6% of the biopsies with polyps. CONCLUSION: The prevalence of gastric polyps is similar to other regions of the world; PGF and hyperplastic are the most frequent. Adenomatous polyps showed a greater relationship with and metaplasia and dysplasia.


Asunto(s)
Pólipos Adenomatosos/epidemiología , Neoplasias Gástricas/epidemiología , Pólipos Adenomatosos/clasificación , Pólipos Adenomatosos/patología , Anciano , Biopsia , Estudios Transversales , Femenino , Mucosa Gástrica/patología , Gastritis/epidemiología , Gastritis/patología , Gastroscopía , Infecciones por Helicobacter/epidemiología , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Hospitales Públicos/estadística & datos numéricos , Hospitales Urbanos/estadística & datos numéricos , Humanos , Hiperplasia , Inflamación , Masculino , Metaplasia , Persona de Mediana Edad , Perú/epidemiología , Prevalencia , Estudios Retrospectivos , Neoplasias Gástricas/clasificación , Neoplasias Gástricas/patología
2.
Rev Gastroenterol Peru ; 37(1): 53-57, 2017.
Artículo en Español | MEDLINE | ID: mdl-28489837

RESUMEN

OBJECTIVE: To validate a rapid urease test (RUT) in Cayetano Heredia Hospital (HCH) in Lima, Peru. MATERIALS AND METHODS: This is a prospective observational study that included 181 patients over 18 years old with dyspeptic symptoms. All of them underwent upper gastrointestinal endoscopy at the Department of Gastroenterology at HCH. They had not received, during the last four weeks, proton pump inhibitors (PPIs), bismuth or antibiotics. Two biopsies of antrum were taken, one to perform the TRU (Sensibacter pylori test®) and the other one for pathology, in order to determine by both methods the presence of H. pylori infection. TRU's results were compared with pathology ́s (gold standard). RESULTS: 181 patients, average age 52.8±13.5 years, were evaluated. The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) at 20 minutes were 86.8%, 98.5%, 81.5% and 99% and at 24 hours 97.3%, 99.5%, 95.7% y 99.1% respectively. CONCLUSION: The rapid urease test is a reliable, accessible and easy to apply test for the diagnosis of H. pylori infection.


Asunto(s)
Mucosa Gástrica/metabolismo , Infecciones por Helicobacter/diagnóstico , Helicobacter pylori/enzimología , Ureasa/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/metabolismo , Biopsia , Femenino , Mucosa Gástrica/microbiología , Mucosa Gástrica/patología , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Hospitales , Humanos , Masculino , Persona de Mediana Edad , Perú , Valor Predictivo de las Pruebas , Estudios Prospectivos , Sensibilidad y Especificidad , Adulto Joven
3.
J Infect Dis ; 213(5): 723-30, 2016 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-26486638

RESUMEN

BACKGROUND: An ecological correlation between invasive cervical cancer incidence and burden of soil-transmitted helminths (STH) is hypothesized to explain the excess in detectable human papillomavirus (HPV) infection in Latin America, via a global T-helper type 2 (Th2)-biased mucosal immune response secondary to STH infection. METHODS: The association between current STH infection and HPV prevalence was compared in regions of Peru where STH is or is not endemic. Adjusted prevalence ratios (PRs) with robust variance were estimated as an effect measure of STH infection on HPV prevalence in each study site. Soluble immune marker profiles in STH-infected and STH-uninfected women were compared using Spearman rank correlation with the Sidak correction. RESULTS: Among women in the helminth-endemic region of the Peruvian Amazon, those with STH infection women had a 60% higher prevalence of HPV, compared with those without STH infection (PR, 1.6; 95% confidence interval, 1.0-2.7). Non-STH parasitic/protozoal infections in the non-STH-endemic population of Peru were not associated with HPV prevalence. In Iquitos, A Th2 immune profile was observed in cervical fluid from helminth-infected women but not helminth-uninfected women. CONCLUSIONS: A proportion of the increased HPV prevalence at older ages observed in Latin America may be due to a population-level difference in the efficiency of immunological control of HPV across the lifespan due to endemic STH infection.


Asunto(s)
Citocinas/metabolismo , Helmintiasis/complicaciones , Helmintiasis/transmisión , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/complicaciones , Suelo/parasitología , Linfocitos T Colaboradores-Inductores/metabolismo , Adulto , Cuello del Útero/metabolismo , Femenino , Regulación de la Expresión Génica/inmunología , Helmintiasis/epidemiología , Humanos , Persona de Mediana Edad , Infecciones por Papillomavirus/epidemiología , Infecciones por Papillomavirus/inmunología , Infecciones por Papillomavirus/metabolismo , Perú/epidemiología , Proyectos Piloto
4.
Rev Gastroenterol Peru ; 35(2): 137-40, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26228979

RESUMEN

OBJECTIVE: This study aims to investigate the relationship between functional gastrointestinal disorders and histopathology characteristics, including H. pylori infection, of gastric mucosa, at Cayetano Heredia National Hospital, Lima-Peru, in 2013. MATERIALS AND METHODS: 112 patients were interviewed prospectively between June and July 2013 in the gastroenterology service. Dyspepsia, irritable bowel syndrome, and postprandial distress syndrome were characterized using the Rome III Survey. RESULTS: Pathology results were determined by gastric biopsies obtained by endoscopy. Of the patients interviewed, biopsy results were obtained for 101. 22.8% had atrophy, 24.8% had intestinal metaplasia, 57.4% presented with H pylori. CONCLUSIONS: Using chi-square analysis, no statistically significant relationship could be identified between clinical presentation and biopsy results.


Asunto(s)
Dispepsia/patología , Mucosa Gástrica/patología , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Síndrome del Colon Irritable/patología , Lesiones Precancerosas/patología , Adolescente , Adulto , Anciano , Biopsia , Dispepsia/diagnóstico , Dispepsia/microbiología , Femenino , Mucosa Gástrica/microbiología , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/microbiología , Humanos , Síndrome del Colon Irritable/diagnóstico , Síndrome del Colon Irritable/microbiología , Masculino , Persona de Mediana Edad , Perú , Lesiones Precancerosas/diagnóstico , Lesiones Precancerosas/microbiología , Estudios Prospectivos , Adulto Joven
5.
J Biol Chem ; 286(34): 29964-72, 2011 Aug 26.
Artículo en Inglés | MEDLINE | ID: mdl-21757722

RESUMEN

Population genetic analyses of bacterial genes whose products interact with host tissues can give new understanding of infection and disease processes. Here we show that strains of the genetically diverse gastric pathogen Helicobacter pylori from Amerindians from the remote Peruvian Amazon contain novel alleles of cagA, a major virulence gene, and reveal distinctive properties of their encoded CagA proteins. CagA is injected into the gastric epithelium where it hijacks pleiotropic signaling pathways, helps Hp exploit its special gastric mucosal niche, and affects the risk that infection will result in overt gastroduodenal diseases including gastric cancer. The Amerindian CagA proteins contain unusual but functional tyrosine phosphorylation motifs and attenuated CRPIA motifs, which affect gastric epithelial proliferation, inflammation, and bacterial pathogenesis. Amerindian CagA proteins induced less production of IL-8 and cancer-associated Mucin 2 than did those of prototype Western or East Asian strains and behaved as dominant negative inhibitors of action of prototype CagA during mixed infection of Mongolian gerbils. We suggest that Amerindian cagA is of relatively low virulence, that this may have been selected in ancestral strains during infection of the people who migrated from Asia into the Americas many thousands of years ago, and that such attenuated CagA proteins could be useful therapeutically.


Asunto(s)
Antígenos Bacterianos/metabolismo , Proteínas Bacterianas/metabolismo , Evolución Molecular , Infecciones por Helicobacter/metabolismo , Helicobacter pylori/metabolismo , Helicobacter pylori/patogenicidad , Factores de Virulencia/metabolismo , Alelos , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , Femenino , Mucosa Gástrica/metabolismo , Mucosa Gástrica/microbiología , Gerbillinae , Infecciones por Helicobacter/genética , Helicobacter pylori/genética , Humanos , Indígenas Sudamericanos , Interleucina-8/genética , Interleucina-8/metabolismo , Masculino , Datos de Secuencia Molecular , Mucina 2/genética , Mucina 2/metabolismo , Perú , Fosforilación , Transducción de Señal/genética , Neoplasias Gástricas/genética , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/microbiología , Factores de Virulencia/genética
6.
Rev Gastroenterol Peru ; 31(2): 169-72, 2011.
Artículo en Español | MEDLINE | ID: mdl-21836657

RESUMEN

Gastrointestinal stromal cell tumors (GIST) are rare neoplasms of the gastrointestinal tract, although they are the most common mesenchymal neoplasms. The stomach and small intestine are the most frequent site of involvement accounting for approximately 85% of cases. However, esophagus involvement is exceptional (<5%); indeed some large series fail to report it. Surgery resection is the cornerstone of treatment; currently imatinib has demonstrated its utility to reduce local recurrences and tumor mass. We report a 75 years-old male with a medical history of dysphagia who presented upper gastrointestinal bleeding caused by an esophageal GIST. The patient did not undergo surgery because of severe chronic heart failure.


Asunto(s)
Neoplasias Esofágicas/patología , Tumores del Estroma Gastrointestinal/patología , Anciano , Antineoplásicos/uso terapéutico , Sulfato de Bario , Benzamidas , Contraindicaciones , Trastornos de Deglución/etiología , Urgencias Médicas , Neoplasias Esofágicas/complicaciones , Neoplasias Esofágicas/diagnóstico , Neoplasias Esofágicas/tratamiento farmacológico , Esofagectomía , Esofagoscopía , Tumores del Estroma Gastrointestinal/complicaciones , Tumores del Estroma Gastrointestinal/diagnóstico , Tumores del Estroma Gastrointestinal/tratamiento farmacológico , Insuficiencia Cardíaca/complicaciones , Humanos , Mesilato de Imatinib , Masculino , Melena/etiología , Piperazinas/uso terapéutico , Pirimidinas/uso terapéutico
7.
Biometals ; 23(3): 515-21, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20306285

RESUMEN

Lactoferrin (LF) has in vitro antimicrobial activity against Gram-negative bacteria. Salmonella enterica subsp. enterica serovar Typhimurium causes systemic infection and acute diarrhea in humans, mainly in children younger than 2 years of age. The aim of the study was to determine the in vivo effect of bovine LF in Salmonella ser. Typhimurium infection in mice. 58 BALB/c mice were employed. Two hours before the infection with 300 microl of 10(7) CFU of Salmonella ser. Typhimurium, 29 mice received LF (2 mg) and 29 placebo (buffer). After the infection, the mice received LF (10 mg/ml) ad libitum or buffer, respectively, for 7 days. Mortality, weight and clinical signs (piloerection, hunched position and reduced movement) were monitored daily. The degree of inflammation and necrosis in the intestine, liver, spleen and brain were studied with a blinded observer. The mortality in the control group (8/29) was higher than in the LF group (1/29) (Kapplan Meier P < 0.05). From the third day post-infection the control group were significantly more symptomatic (P < 0.05). The blood culture for Salmonella spp. was positive for all mice studied in the control group (17/17), but positive in the LF group in only 6/17 animals (P < 0.05). In the LF group, the pathologic studies show less inflammation and focal necrosis in the four organs studied, with the greatest difference found in the intestine. Bovine LF protects against Salmonella ser. Typhimurium infection in mice, reducing the severity, mortality and the degree of inflammation of this infection.


Asunto(s)
Lactoferrina/farmacología , Salmonelosis Animal/tratamiento farmacológico , Salmonelosis Animal/microbiología , Salmonella typhimurium , Animales , Antibacterianos/inmunología , Antibacterianos/farmacología , Peso Corporal/efectos de los fármacos , Bovinos , Femenino , Inflamación , Lactoferrina/inmunología , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Salmonelosis Animal/inmunología , Salmonelosis Animal/patología , Salmonella typhimurium/aislamiento & purificación , Tasa de Supervivencia
8.
Front Microbiol ; 11: 601839, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33381095

RESUMEN

Region-specific Helicobacter pylori subpopulations have been identified. It is proposed that the hspAmerind subpopulation is being displaced from the Americans by an hpEurope population following the conquest. Our study aimed to describe the genomes and methylomes of H. pylori isolates from distinct Peruvian communities: 23 strains collected from three groups of Native Americans (Asháninkas [ASHA, n = 9], Shimaas [SHIM, n = 5] from Amazonas, and Punos from the Andean highlands [PUNO, n = 9]) and 9 modern mestizos from Lima (LIM). Closed genomes and DNA modification calls were obtained using SMRT/PacBio sequencing. We performed evolutionary analyses and evaluated genomic/epigenomic differences among strain groups. We also evaluated human genome-wide data from 74 individuals from the selected Native communities (including the 23 H. pylori strains donors) to compare host and bacterial backgrounds. There were varying degrees of hspAmerind ancestry in all strains, ranging from 7% in LIM to 99% in SHIM. We identified three H. pylori subpopulations corresponding to each of the Native groups and a novel hspEuropePeru which evolved in the modern mestizos. The divergence of the indigenous H. pylori strains recapitulated the genetic structure of Native Americans. Phylogenetic profiling showed that Orthogroups in the indigenous strains seem to have evolved differentially toward epigenomic regulation and chromosome maintenance, whereas OGs in the modern mestizo (LIM) seem to have evolved toward virulence and adherence. The prevalence of cagA +/vacA s1i1m1 genotype was similar across populations (p = 0.32): 89% in ASHA, 67% in PUNO, 56% in LIM and 40% in SHIM. Both cagA and vacA sequences showed that LIM strains were genetically differentiated (p < 0.001) as compared to indigenous strains. We identified 642 R-M systems with 39% of the associated genes located in the core genome. We found 692 methylation motifs, including 254 population-specific sequences not previously described. In Peru, hspAmerind is not extinct, with traces found even in a heavily admixed mestizo population. Notably, our study identified three new hspAmerind subpopulations, one per Native group; and a new subpopulation among mestizos that we named hspEuropePeru. This subpopulation seems to have more virulence-related elements than hspAmerind. Purifying selection driven by variable host immune response may have shaped the evolution of Peruvian subpopulations, potentially impacting disease outcomes.

10.
Am J Trop Med Hyg ; 97(4): 1271-1276, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-29031289

RESUMEN

The differential diagnosis for lymphadenopathy is wide and clinical presentations overlap, making obtaining an accurate diagnosis challenging. We sought to characterize the clinical and radiological characteristics, histological findings, and diagnoses for a cohort of patients with lymphadenopathy of unknown etiology. 121 Peruvian adults with lymphadenopathy underwent lymph node biopsy for microbiological and histopathological evaluation. Mean patient age was 41 years (Interquartile Range 26-52), 56% were males, and 39% were HIV positive. Patients reported fever (31%), weight loss (23%), and headache (22%); HIV infection was associated with fever (P < 0.05) and gastrointestinal symptoms (P < 0.05). Abnormalities were reported in 40% of chest X-rays (N = 101). Physicians suspected TB in 92 patients (76%), lymphoma in 19 patients (16%), and other malignancy in seven patients (5.8%). Histological diagnoses (N = 117) included tuberculosis (34%), hyperplasia (27%), lymphoma (13%), and nonlymphoma malignancy (14%). Hyperplasia was more common (P < 0.001) and lymphoma less common (P = 0.005) among HIV-positive than HIV-negative patients. There was a trend toward reduced frequency of caseous necrosis in samples from HIV-positive than HIV-negative TB patients (67 versus 93%, P = 0.055). The spectrum of diagnoses was broad, and clinical and radiological features correlated poorly with diagnosis. On the basis of clinical features, physicians over-diagnosed TB, and under-diagnosed malignancy. Although this may not be inappropriate in resource-limited settings where TB is the most frequent easily treatable cause of lymphadenopathy, diagnostic delays can be detrimental to patients with malignancy. It is important that patients with lymphadenopathy undergo a full diagnostic work-up including sampling for histological evaluation to obtain an accurate diagnosis.


Asunto(s)
Linfadenopatía/diagnóstico , Linfadenopatía/patología , Adulto , Biopsia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Perú
11.
Oncotarget ; 8(24): 38501-38516, 2017 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-28418867

RESUMEN

Clinically useful molecular tools to triage gastric cancer patients are not currently available. We aimed to develop a molecular tool to predict gastric cancer risk in endoscopy-driven biopsies obtained from high-risk gastric cancer clinics in low resource settings.We discovered and validated a DNA methylation biomarker panel in endoscopic samples obtained from 362 patients seen between 2004 and 2009 in three high-risk gastric cancer clinics in Lima, Perú, and validated it in 306 samples from the Cancer Genome Atlas project ("TCGA"). Global, epigenome wide and gene-specific DNA methylation analyses were used in a Phase I Biomarker Development Trial to identify a continuous biomarker panel that combines a Global DNA Methylation Index (GDMI) and promoter DNA methylation levels of IRF4, ELMO1, CLIP4 and MSC.We observed an inverse association between the GDMI and histological progression to gastric cancer, when comparing gastritis patients without metaplasia (mean = 5.74, 95% CI, 4.97-6.50), gastritis patients with metaplasia (mean = 4.81, 95% CI, 3.77-5.84), and gastric cancer cases (mean = 3.38, 95% CI, 2.82-3.94), respectively (p < 0.0001). Promoter methylation of IRF4 (p < 0.0001), ELMO1 (p < 0.0001), CLIP4 (p < 0.0001), and MSC (p < 0.0001), is also associated with increasing severity from gastritis with no metaplasia to gastritis with metaplasia and gastric cancer.Our findings suggest that IRF4, ELMO1, CLIP4 and MSC promoter methylation coupled with a GDMI>4 are useful molecular tools for gastric cancer risk stratification in endoscopic biopsies.


Asunto(s)
Adenocarcinoma/diagnóstico , Biomarcadores de Tumor/genética , Detección Precoz del Cáncer/métodos , Neoplasias Gástricas/diagnóstico , Proteínas Adaptadoras Transductoras de Señales/genética , Adenocarcinoma/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Biopsia , Proteínas Portadoras/genética , Metilación de ADN/genética , Femenino , Gastroscopía , Estudio de Asociación del Genoma Completo , Humanos , Factores Reguladores del Interferón/genética , Masculino , Proteínas de la Membrana , Persona de Mediana Edad , Neoplasias Gástricas/genética , Adulto Joven
12.
Rev Inst Med Trop Sao Paulo ; 48(5): 295-9, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17086321

RESUMEN

Rhinoscleroma is a rare infection in developed countries; although, it is reported with some frequency in poorer regions such as Central Africa, Central and South America, Eastern and Central Europe, Middle East, India and Indonesia. Nowadays, rhinoscleroma may be erroneously diagnosed as mucocutaneos leishmaniasis, leprosy, paracoccidioidomycosis, rhinosporidiasis, late syphilis, neoplasic diseases or other upper airway diseases. From 1996 to 2003, we diagnosed rhinoscleroma in eight patients attended in the Dermatologic and Transmitted Diseases service of "Cayetano Heredia" National Hospital, in Lima, Peru. The patients presented airway structural alterations producing nasopharyngeal, oropharyngeal and, in one patient, laryngeal stenosis. Biopsy samples revealed large vacuolated macrophages (Mikulicz cells) in all patients. Ciprofloxacin 500 mg bid for four to 12 weeks was used in seven patients and oxytetracycline 500 mg qid for six weeks in one patient. After follow-up for six to 12 months the patients did not show active infection or relapse, however, all of them presented some degree of upper airway stenosis. These cases are reported because of the difficulty diagnosing the disease and the success of antibiotic treatment.


Asunto(s)
Antibacterianos/uso terapéutico , Ciprofloxacina/uso terapéutico , Oxitetraciclina/uso terapéutico , Rinoscleroma/diagnóstico , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Perú , Rinoscleroma/tratamiento farmacológico , Resultado del Tratamiento
14.
Rev Inst Med Trop Sao Paulo ; 44(6): 325-30, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12532216

RESUMEN

Cat-Scratch Disease (CSD) is a benign lymphadenitis that may progress to severe or recurrent forms, and it is occasionally associated with morbidity. Between January of 1998 and March of 1999, forty-three suspected CSD patients were assessed in the Hospital Cayetano Heredia and the Instituto de Salud del Niño, in Lima, Peru. Twelve patients had a confirmed diagnosis, 8 of whom were women, and the mean age was 10 years old. The majority (53%) of the cases were encountered in the summer. All patients reported having had contact with cats. Fever, malaise, lymphadenopathy and skin lesions were the most frequent clinical features. Twelve patients had indirect immunofluorescence antibody test titers of between 1/50 and 1/800 for Bartonella henselae and Bartonella clarridgeiae. Two lymph node biopsies were histologically compatible with CSD. No positive blood cultures could be obtained. This is the first Peruvian prospective study able to identify B. henselae and B. clarridgeiae in pediatric patients.


Asunto(s)
Enfermedad por Rasguño de Gato/diagnóstico , Adolescente , Adulto , Bartonella/aislamiento & purificación , Bartonella henselae/aislamiento & purificación , Enfermedad por Rasguño de Gato/sangre , Niño , Preescolar , Femenino , Humanos , Ganglios Linfáticos/microbiología , Ganglios Linfáticos/patología , Masculino , Perú , Estudios Prospectivos
15.
Rev Gastroenterol Peru ; 20(4): 395-405, 2000.
Artículo en Español | MEDLINE | ID: mdl-12140574

RESUMEN

Histopathologic findings in Nodular Gastritis at Cayetano Heredia National Hospital.Nodular Gastritis (NG) is not a so unfrequently finding in adults. From January 1994 to April 1997, 261 patientes from a total number of 3600 that were submitted to an upper endoscopy at Cayetano Heredia National Hospital in Lima, Per , had this finding. The aim of this study is to find whether there is a characteristic histopathologic pattern in NG. Material and methods : 112 endoscopy reports with the diagnosis of NG that at the same time had biopsies, were reviewed. These patients were compared to a group matched for age and sex with an endoscopic finding of normality, or a diagnosis different from NG, excluding diagnosis of gastric or duodenal ulcers, duodenitis or neoplasia, that had also biopsies. The biopsies of both groups were reviewed by an experimented pathologist in a double blind fashion. The following parameters were considered : Presence and type of gastritis, presence and grade of mucosal inflammation, presence and type of intestinal metaplasia, presence and degree of inflammatory activity, presence and number of lymphoid follicles, presence and number of eosinophils in the mucosa, presence of Helicobacter pylori and edema.RESULTS : Significative statistic difference was found in the group of patients with NG on the following parameters: grade of mucosal inflammation, gastritis activity, presence of eosinophils and presence of Helicobacter pylori. Conclusion : NG is a chronic gastritis with superficial eosinophilic infiltration and a very important inflammatory activity associated to the presence of Helicobacter pylori. Further studies are required to determine the cause for these histopathologic findings.

16.
Rev Gastroenterol Peru ; 19(1): 15-25, 1999.
Artículo en Español | MEDLINE | ID: mdl-12177705

RESUMEN

In this work, 60 patients with an hepatocarcinoma diagnosis, corrobarated with hepatic biopsies at the Hospital Cayetano Heredia, between 1969 and 1997, are studied to determine clinical presentation and laboratory findings of this entity within us. The early hepatocarcinoma cases studied were 60. The age group that suffered mostly from this pathology was between 60 to 69 years (23.33%), followed by the age group of 20 to 29 years (20%). While the mean age was of 45 years. 56.66% were male, and 43.33% were female. 56.66% of cases came from the Coast, 30% from the Mountains, and 13.33% from the Jungle. Cronic and excessive alcohol ingestion appeared as background in 25% of cases. The average period of apparent disease was seven (7) weeks. The main symptoms at their admission were: abdominal mass sensation (81.66%), weight loss (81.66%) superior hemiabdominal pain (80%), and anorexia (60%). In 95% of cases the predominant sign was Hepatomegaly. The survival term of those patients whom we were able to follow-up was of less than six (6) months in 86.84 /x, less or equal to.

17.
Rev Gastroenterol Peru ; 17(3): 203-213, 1997.
Artículo en Español | MEDLINE | ID: mdl-12177714

RESUMEN

As Helicobacter pylori infection represents a very important causal factor in the development of duodenal peptic ulcer, several therapeutic trials have been developed in order to obtain an efficient eradication of the microorganism. The aim of our study has been to evaluate, in patients with duodenal peptic ulcer, the effect of double antibiotic short therapy associated to famotidine on the eradication of Helicobacter pylori, cicatrization of ulcerous lesion and the histological changes after the treatment. Forty patients with duodenal ulcer and Helicobacter pylori infection were distributed al random in two groups (I and II). Group I received tetracycline 2 gr per day plus furazolidone 400 mg per day for a week, and famotidine 40 mg per day for four weeks. Group II received just famotidine 40 mg per day for six weeks. Al the initial endoscopy, four biopsies were taken from the gastric antrurn for histological study and determination of Helicobacter pylori. The endoscopy was repeated between 6 and 8 weeks after the beginning of the antibiotic treatment, when four biopsies were taken again from the gastric antrum with the same purpose, and the results were compared. Twenty-eight patients completed the study, 14 in group I and 14 in group II. Helicobacter pylori eradication was obtained in 85,7% of patients in group I and 0% in group II (p=0.00002). Ulcer cicatrization was obtained in 100% of patients of group I compared to 85,7% of patients of group II (p=0.48). The histological degree of gastritis significantly diminished after the treatment in patients of Group I, in relation to the histological parameters of severity (p=0,002), activity (p=0,00002) and presence of lymphoid follicles (p=0.02). These changes were not significantly observed in group II. Two patients of group I had mild sideeffects (14,3%), and none of them was observed in group II (p=0.48). We concluded that the treatment used (tetracycline + furazolidone) was highly efficacious in the eradication of Helicobacter pylori, as well as in the cicatrization, reduction of antral gastric mucous inflammation, and a low rate of side-effects.

18.
Rev Gastroenterol Peru ; 17(1): 31-43, 1997.
Artículo en Español | MEDLINE | ID: mdl-12221435

RESUMEN

We present a prospective study of 68 patients with the acute phase of human bartonellosis, admitted to Cayetano Heredia National Hospital.Gastrointestinal symptoms were reported as follows: abdominal pain 46,3%, coluria 44,4%, vomiting 40,3%, jaundice 38,5%, diarrhea 29,9%, constipation 8,9%. The more common signs were pallor 97%, hepatomegaly 82%, fever 79,1%, malnutrition 75,2%, systolic heart murmur 77,9%, jaundice 71,6%, lymph node enlargement 70,1%.Signs observed during the hospital course were 29,4% lower extremities edema, 22,6% myalgia, 16,4% pericardial effusion, 16,4% generalized edema. The more common gastrointestinal signs were hepatomegaly 82%(52/68), jaundice 71,6% (48/68) and splenomegaly 29,4%(20/68).The -lower liver border was found between 1 to 4 below the lower rib border in 71,6%(48/67) and below 5 cm b. l. r. b. in 11,9%(8/67).60% had abnormal liver function tests, 54,6% had mainly direct bilirrubin elevationand 45,4% mainly indirect.SGOT was elevated in 28,5% and SGPT in 25%, 28,3% had elevated alkaline phosphatase. The bilirrubin media was 3,5 mg/dI (range 0,6-21), the indirect bilirrubin media was 1,6 mg/dI (range 0,5-11,5), the direct bilirrubin media was 1,9 mg/dI (range 0,3-18), The SGOT media 73,9 U/L (range 9-1250), SGPT media 65,5U/L (range 6-1596). Alkaline phosphatase 5,9 mui/ml (range 3-497). Albumin media 3,09 (range 2-4,2).Patients with bacterial coinfection (salmonella, staphilococcus, enterobacter, shigella) had a higher increase in bilirrubin and transaminases.Three patients had liver biopsies, two revealed Küpffer cells hyperplasia (moderate to severe), one revealed intracellular hyperplasia, one patient coinfected with diseminated hystoplasmosis had granulomas in the liver.Mortality(8,8%) was associated to hepatocellular involvement (SGOT media 330U/L, SGPT media 207 U/L, alkaline phosphatase media 183 mui/ml), hypoalbuminemia media = 2,4 gr/1) and generalized edema.

19.
Rev Gastroenterol Peru ; 19(3): 179-194, 1999.
Artículo en Español | MEDLINE | ID: mdl-12207204

RESUMEN

BACKGROUND: Helicobacter pylori (HP) infection is very prevalent worldwide, and has been associated with the presence of duodenal ulcer, gastric ulcer and chronic active gastritis. It is also speculated that HP may have a role in gastric cancer development. Triple drug schemes have been shown to be the most effective approach to erradicate HP infection. Nevetheless, high rates of resistance against some antibiotics as well as high costs affect the effectiveness of these therapies. The goal of the present study is to assess the effectiveness of the combination of tetracycline, furazolidone and bismuth in erradicating HP, as well as the changes in the histology.METHODS: Patients with diagnosis of HP infection, found in their antral gastric biopsies (hematoxylin and eosin staining (H-E)), were included. They received the following scheme for 10 days: tetracycline 500 mg qid., furazolidone 100 mg qid., and colloidal bismuth subcitrate 120 mg qid. Patients were instructed to come back for follow-up 6 to 8 weeks after starting the therapy. At that time a control upper endoscopy was performed and 3 antral biopsies were taken. Biopsies were stained with H-E and read by experienced pathologists. In both, the biopsy before treatment and the control biopsy, the following parameters were looked for: presence and density of HP; presence, depth and grade of chronic gastritis (lymphoplasmocytic infiltrate); presence and grade of inflammatory activity (polymorphonuclear inflitrate); presence of glandular atrophy; presence, grade (partial or total) and extent (focal or multifocal) of mucinous damage (epithelial damage); presence of intestinal metaplasia; and presence of lymphoid follicles.RESULTS: Fifty-nine patients (30 men and 29 women) completed per protocol. Mean age was 43 +/- 18 (range: 14-73). HP erradication was achieved in 54 patients (91.5%). Control biopsies showed improvement in the following parameters: presence and density of HP (p<0.001); presence, depth and grade of chronic gastritis (p<0.001); presence and grade of inflammatory activity (p<0.001); presence, grade and extent of mucinous damage (p<0.001); and presence of lymphoid follicles (p<0.001). Neither the presence of glandular atrophy nor the presence of intestinal metaplasia showed any significant change. Patients who did not erradicate HP showed no significant difference in any of the parameters.CONCLUSIONS: The triple drug scheme including tetracycline, furazolidone and bismuth is effective in HP erradication. Erradication of HP is followed by an improvement in the following histologic parameters: presence, depth and grade of chronic gastritis (LMN infiltrate); presence and grade of inflammatory activity (PMN infiltrate); presence, grade and extent of mucinous damage; and presence of lymphoid follicles. This scheme is a cost-effective alternative for the therapy of HP infection in low income populations with a high prevalence of infection with this bacteria.

20.
Rev. gastroenterol. Perú ; 39(1): 12-20, ene.-mar. 2019. ilus, tab
Artículo en Español | LILACS | ID: biblio-1014121

RESUMEN

Objetivos: Determinar la prevalencia de pólipos gástricos detectados mediante endoscopía digestiva alta, en pacientes mayores de 18 años del Hospital Cayetano Heredia, en el periodo 2007-2016. Materiales y métodos: Estudio retrospectivo de corte transversal, realizado con datos de biopsias gástricas de pacientes sometidos a endoscopía digestiva alta entre enero de 2007 y julio de 2016. Se evaluó cambios histológicos asociados, datos demográficos y características endoscópicas, las cuales fueron sometidas a análisis estadístico mediante STATA v14.2. Resultados: En una población de 16 552 endoscopías realizadas, se encontró 407 biopsias compatibles con pólipos gástricos, lo cual da una prevalencia de 2,5%. Los pólipos gástricos fueron más frecuentes en mujeres (62,38%). La mediana de edad fue de 61 años (52-71 años). El tipo histológico más frecuente fue el pólipo glandular fúndico (PGF) (44,85%), seguido de pólipo hiperplásico (38,48%) y adenomatoso (15,23%). La localización más frecuente fue en fondo/cuerpo (48,65%, p=0,001) Se detectó la presencia de Helicobacter pylori (Hp) en el 30,6% de las biopsias compatibles con pólipos. Conclusión: La prevalencia de pólipos gástricos es similar con otras regiones del mundo; los PGF e hiperplásicos son los más frecuentes. Los pólipos adenomatosos estuvieron en mayor relación a cambios como metaplasia y displasia.


Objectives: Establish the prevalence of gastric polyps detected by upper gastrointestinal endoscopy in patients older than 18 years old during the period from 2007 - 2016 in Cayetano Heredia Hospital. Materials and methods: Retrospective cross- sectional study, performed with data from the gastric biopsies reports of patients that have undergone upper gastrointestinal endoscopy between January 2007 and July 2016. Demographic data, endoscopic characteristics of the polyps and associated histological changes of the surrounding gastric mucosa were evaluated, which were subjected to statistical analysis using STATA v14.2. Results: In a population of 16 552 endoscopies, 407 gastric polyps biopsies were found. These results give a prevalence of 2.5% .Gastric polyps were detected predominantly in women (62.38%). The median age was 61 years (52-71 years). The most frequent histological type was the fundic gland polyp (FGP) (44.85%), followed by the hyperplastic (38.48%) and adenomatous (15.23%) polyp. The most frequent location was in the fundus / corpus (48.65%, p = 0.001). The presence of Hp was detected in 30.6% of the biopsies with polyps. Conclusion: The prevalence of gastric polyps is similar to other regions of the world; PGF and hyperplastic are the most frequent. Adenomatous polyps showed a greater relationship with and metaplasia and dysplasia.


Asunto(s)
Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Gástricas/epidemiología , Pólipos Adenomatosos/epidemiología , Perú/epidemiología , Neoplasias Gástricas/clasificación , Neoplasias Gástricas/patología , Biopsia , Hospitales Urbanos/estadística & datos numéricos , Prevalencia , Estudios Transversales , Estudios Retrospectivos , Helicobacter pylori/aislamiento & purificación , Infecciones por Helicobacter/patología , Infecciones por Helicobacter/epidemiología , Gastroscopía , Pólipos Adenomatosos/clasificación , Pólipos Adenomatosos/patología , Mucosa Gástrica/patología , Gastritis/patología , Gastritis/epidemiología , Hospitales Públicos/estadística & datos numéricos , Hiperplasia , Inflamación , Metaplasia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA